(-0.34%) 5 018.39 points
(0.23%) 37 903 points
(-0.33%) 15 605 points
(0.61%) $79.48
(1.19%) $1.955
(0.83%) $2 330.10
(0.40%) $26.86
(1.34%) $967.70
(-0.01%) $0.933
(-0.04%) $11.03
(-0.08%) $0.798
(0.27%) $93.51
0.00% HKD 2.02
Live Chart Being Loaded With Signals
IVD Medical Holding Limited, an investment holding company, distributes In vitro diagnostic (IVD) products in Mainland China and internationally. The company operates through three segments: Distribution Business, Maintenance Services, and Self-branded Products Business...
Stats | |
---|---|
Объем за сегодня | 6 000.00 |
Средний объем | 109 578 |
Рыночная капитализация | 2.74B |
EPS | HKD0 ( 2023-08-18 ) |
Last Dividend | HKD0.0297 ( 2023-09-04 ) |
Next Dividend | HKD0 ( N/A ) |
P/E | 10.63 |
ATR14 | HKD0.0600 (2.97%) |
Ivd Medical Holding Ltd Корреляция
10 Самые положительные корреляции |
---|
10 Самые отрицательные корреляции |
---|
Вы знали?
Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).
Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.
Ivd Medical Holding Ltd Финансовые показатели
Annual | 2022 |
Выручка: | HKD2.75B |
Валовая прибыль: | HKD608.14M (22.12 %) |
EPS: | HKD0.160 |
FY | 2022 |
Выручка: | HKD2.75B |
Валовая прибыль: | HKD608.14M (22.12 %) |
EPS: | HKD0.160 |
FY | 2021 |
Выручка: | HKD2.73B |
Валовая прибыль: | HKD566.27M (20.74 %) |
EPS: | HKD0.131 |
FY | 2020 |
Выручка: | HKD2.43B |
Валовая прибыль: | HKD476.17M (19.61 %) |
EPS: | HKD0.119 |
Financial Reports:
No articles found.
Ivd Medical Holding Ltd Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0.0273 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0.0594 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | HKD0.0537 | 2020-06-05 |
Last Dividend | HKD0.0297 | 2023-09-04 |
Next Dividend | HKD0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 8 | -- |
Total Paid Out | HKD0.273 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.53 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 5.20 | |
Div. Directional Score | 8.18 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
9982.HK | Ex Dividend Knight | 2023-12-12 | Semi-Annually | 0 | 0.00% | |
2191.HK | Ex Dividend Knight | 2023-08-30 | Semi-Annually | 0 | 0.00% | |
1193.HK | Ex Dividend Knight | 2023-05-30 | Semi-Annually | 0 | 0.00% | |
0267.HK | Ex Dividend Junior | 2023-09-22 | Semi-Annually | 0 | 0.00% | |
3900.HK | Ex Dividend Junior | 2023-06-20 | Sporadic | 0 | 0.00% | |
1766.HK | Ex Dividend Junior | 2023-06-21 | Annually | 0 | 0.00% | |
0808.HK | Ex Dividend Junior | 2023-08-31 | Semi-Annually | 0 | 0.00% | |
2348.HK | Ex Dividend Knight | 2023-09-19 | Annually | 0 | 0.00% | |
1319.HK | Ex Dividend Knight | 2023-08-02 | Semi-Annually | 0 | 0.00% | |
0384.HK | Ex Dividend Knight | 2023-08-25 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0786 | 1.500 | 8.43 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0509 | 1.200 | 8.30 | 9.96 | [0 - 0.3] |
returnOnEquityTTM | 0.0730 | 1.500 | -0.301 | -0.451 | [0.1 - 1] |
payoutRatioTTM | 0.251 | -1.000 | 7.49 | -7.49 | [0 - 1] |
currentRatioTTM | 2.41 | 0.800 | 2.96 | 2.37 | [1 - 3] |
quickRatioTTM | 1.552 | 0.800 | 5.58 | 4.46 | [0.8 - 2.5] |
cashRatioTTM | 1.102 | 1.500 | 4.99 | 7.48 | [0.2 - 2] |
debtRatioTTM | 0.113 | -1.500 | 8.11 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 0 | 1.000 | -1.111 | -1.111 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.356 | 2.00 | 9.88 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.324 | 2.00 | 9.84 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.161 | -1.500 | 9.36 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.218 | 1.000 | 9.70 | 9.70 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.123 | 1.000 | 9.55 | 9.55 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.934 | 1.000 | 5.92 | 5.92 | [0.2 - 2] |
assetTurnoverTTM | 0.648 | 0.800 | 9.02 | 7.21 | [0.5 - 2] |
Total Score | 11.16 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 10.68 | 1.000 | 9.02 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0730 | 2.50 | -0.193 | -0.451 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.324 | 2.00 | 9.89 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 3.24 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.356 | 2.00 | 9.88 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.251 | 1.500 | 7.49 | -7.49 | [0 - 1] |
pegRatioTTM | 0 | 1.500 | -3.33 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.163 | 1.000 | 8.42 | 0 | [0.1 - 0.5] |
Total Score | 5.20 |
Ivd Medical Holding Ltd
IVD Medical Holding Limited, an investment holding company, distributes In vitro diagnostic (IVD) products in Mainland China and internationally. The company operates through three segments: Distribution Business, Maintenance Services, and Self-branded Products Business. It offers IVD analysers, reagents, and other consumables for various IVD testing categories, including hematology and body fluid, immunoassay, clinical chemistry, molecular, microbiology, and point-of-care testing. The company also provides haemostasis products; solution services to the clinical laboratories of hospitals; and maintenance services, such as maintenance and repair, installation, and end customer training services. In addition, it researches, develops, manufactures, and sells IVD analyzers and reagents under the IVD brand. The company offers its products to hospitals and healthcare institutions, logistics providers, and distributors. IVD Medical Holding Limited was founded in 1993 and is headquartered in Shanghai, the People's Republic of China.
О Торговые сигналы
Данные торговые сигналы, представленные на этой странице, помогают определить, когда следует ПОКУПАТЬ или ПРОДАВАТЬ NA. Сигналы имеют задержку более 1 минуты. Пожалуйста, примите во внимание, что существует вероятность ошибки или неточностей в силу различных микро и макро факторов влияющих на фондовые рынки.
Данные тор“о”ые сигна“ы не являются определен“ыми, и getagraph.com не несет ответственности за какие-либо действия, предпринятые в от“ошении этих сигналов, как описано в Terms of Use. Сигналы основаны на широком спектре индикаторов технического анализа